These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 3179181)
1. The effect of fractionation of light treatment on necrosis and vascular function of normal skin following photodynamic therapy. Benstead K; Moore JV Br J Cancer; 1988 Sep; 58(3):301-5. PubMed ID: 3179181 [TBL] [Abstract][Full Text] [Related]
2. Vascular function and the probability of skin necrosis after photodynamic therapy: an experimental study. Benstead K; Moore JV Br J Cancer; 1988 May; 57(5):451-4. PubMed ID: 3395550 [TBL] [Abstract][Full Text] [Related]
3. The effect of combined modality treatment with ionising radiation and TPPS-mediated photodynamic therapy on murine tail skin. Benstead K; Moore JV Br J Cancer; 1990 Jul; 62(1):48-53. PubMed ID: 2390482 [TBL] [Abstract][Full Text] [Related]
4. Quantitative histological changes in murine tail skin following photodynamic therapy. Benstead K; Moore JV Br J Cancer; 1989 Apr; 59(4):503-9. PubMed ID: 2469453 [TBL] [Abstract][Full Text] [Related]
5. The effect of light fractionation with a 2-h dark interval on the efficacy of topical hexyl-aminolevulinate photodynamic therapy in normal mouse skin. Middelburg TA; de Bruijn HS; van der Ploeg-van den Heuvel A; Neumann HA; Robinson DJ Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):703-9. PubMed ID: 24284130 [TBL] [Abstract][Full Text] [Related]
6. Necrosis of murine tail skin following photodynamic treatment with meso-tetra-(p-sulphophenyl) porphine (TPPS). Moore JV Photochem Photobiol; 1987 Jun; 45(6):791-4. PubMed ID: 3628503 [No Abstract] [Full Text] [Related]
7. Dose and timing of the first light fraction in two-fold illumination schemes for topical ALA-mediated photodynamic therapy of hairless mouse skin. Robinson DJ; de Bruijn HS; Star WM; Sterenborg HJ Photochem Photobiol; 2003 Mar; 77(3):319-23. PubMed ID: 12685661 [TBL] [Abstract][Full Text] [Related]
8. Topical 5-aminolevulinic acid-photodynamic therapy of hairless mouse skin using two-fold illumination schemes: PpIX fluorescence kinetics, photobleaching and biological effect. Robinson DJ; de Bruijn HS; de Wolf WJ; Sterenborg HJ; Star WM Photochem Photobiol; 2000 Dec; 72(6):794-802. PubMed ID: 11140268 [TBL] [Abstract][Full Text] [Related]
9. Dose-response relationships for photodynamic injury to murine skin. Moore JV; Keene JP; Land EJ Br J Radiol; 1986 Mar; 59(699):257-61. PubMed ID: 3947839 [TBL] [Abstract][Full Text] [Related]
10. Vascular function and tissue injury in murine skin following hyperthermia and photodynamic therapy, alone and in combination. Moore JV; West CM; Haylett AK Br J Cancer; 1992 Dec; 66(6):1037-43. PubMed ID: 1457342 [TBL] [Abstract][Full Text] [Related]
11. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow. Chan WS; Brasseur N; La Madeleine C; van Lier JE Anticancer Res; 1996; 16(4A):1887-92. PubMed ID: 8712717 [TBL] [Abstract][Full Text] [Related]
12. Histologic changes associated with talaporfin sodium-mediated photodynamic therapy in rat skin. Moy WJ; Yao J; de Feraudy SM; White SM; Salvador J; Kelly KM; Choi B Lasers Surg Med; 2017 Oct; 49(8):767-772. PubMed ID: 28489260 [TBL] [Abstract][Full Text] [Related]
13. Long-term regression of the murine mammary adenocarcinoma, LM3, by repeated photodynamic treatments using meso-tetra (4-N-methylpyridinium) porphine. Colombo LL; Vanzulli SI; Villanueva A; Cañete M; Juarranz A; Stockert JC Int J Oncol; 2005 Oct; 27(4):1053-9. PubMed ID: 16142323 [TBL] [Abstract][Full Text] [Related]
14. Early changes in blood flow of the mouse skin after irradiation as measured by the 133Xe clearance method. Tsujii H; Irie G Radiat Med; 1983; 1(4):320-5. PubMed ID: 6680211 [TBL] [Abstract][Full Text] [Related]
15. Effect of photodynamic therapy on blood flow in normal and tumor vessels. Wieman TJ; Mang TS; Fingar VH; Hill TG; Reed MW; Corey TS; Nguyen VQ; Render ER Surgery; 1988 Sep; 104(3):512-7. PubMed ID: 2970687 [TBL] [Abstract][Full Text] [Related]
16. Skin necrosis due to photodynamic action of benzoporphyrin depends on circulating rather than tissue drug levels: implications for control of photodynamic therapy. Lin GC; Tsoukas ML; Lee MS; González S; Vibhagool C; Anderson RR; Kollias N Photochem Photobiol; 1998 Oct; 68(4):575-83. PubMed ID: 9796441 [TBL] [Abstract][Full Text] [Related]
17. Combining vascular and cellular targeting regimens enhances the efficacy of photodynamic therapy. Chen B; Pogue BW; Hoopes PJ; Hasan T Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1216-26. PubMed ID: 15752904 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic ratio of photodynamic therapy in the treatment of superficial tumours of skin and subcutaneous tissues in man. Gilson D; Ash D; Driver I; Feather JW; Brown S Br J Cancer; 1988 Nov; 58(5):665-7. PubMed ID: 2975499 [TBL] [Abstract][Full Text] [Related]
19. Uptake, localization, and photodynamic effect of meso-tetra(hydroxyphenyl)porphine and its corresponding chlorin in normal and tumor tissues of mice bearing mammary carcinoma. Peng Q; Moan J; Ma LW; Nesland JM Cancer Res; 1995 Jun; 55(12):2620-6. PubMed ID: 7780978 [TBL] [Abstract][Full Text] [Related]
20. Light fractionation does not enhance the efficacy of methyl 5-aminolevulinate mediated photodynamic therapy in normal mouse skin. de Bruijn HS; de Haas ER; Hebeda KM; van der Ploeg-van den Heuvel A; Sterenborg HJ; Neumann HA; Robinson DJ Photochem Photobiol Sci; 2007 Dec; 6(12):1325-31. PubMed ID: 18046489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]